Manufacturer of Arrabina® — Nature's Best Dietary Fiber, Perfected. COMET is an award-winning food ingredients company based in London, Ontario, and Schaumburg, Illinois. COMET's proprietary line of Arrabina dietary fibers are upcycled certified and can easily be added to any food and beverage application. sustainability, dietary fiber, prebiotics, sugar reduction, food technology, food ingredients, upcycling, gut health, digestive health, gut microbiome, food innovation, and upcycling

Type: Startup Activities: agritech foodtech manufacturing Technologies: Decarbonization

Solving for today. Building for tomorrow. BIOTECanada is the national industry association voice. With over 230 member companies, the Association’s membership is representative of the broader Canadian biotech ecosystem which is national in scope and comprised of pre-commercial biotech companies, global pharma and biotech companies, investors, incubator and accelerator organizations, and academia. In the context of global population growth and corresponding climate change, food sustainability, and human health needs, the biotechnology industry plays a vital role in developing solutions to help address the resulting human health and environmental challenges.

61 similar entities Type: SMB Activities: deeptech biotech Technologies: Decarbonization

Maintain vision and improve ocular health Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com Pharmaceuticals, Ophthalmology, and Research and Development

69 similar entities Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology

iGEM Startups supports the entrepreneurial community as they help accelerate the transition to a more sustainable world. Acting as the driving force behind hundreds of synthetic biology startup companies and supporting iGEM's budding entrepreneurial community, the iGEM Startups Program helps pre-entrepreneurs accelerate their entry into the global bioeconomy.

Type: Incubators & VCs

Come for a VC bootcamp, stay for the community. First bootcamp for those who aspire to join the venture capital community. A unique program during which a group of aspiring VCs meet those who make venture capital. They reveal to us behind the scenes, the secrets and the future of their profession. Have a look at our job board here: https://www.babyvc.co/careers Are you a venture capital fund or startup looking for a stellar addition to your team? Then add your job offer via this form: https://airtable.com/shrYcgd6zU6VAKlRL, and get access to our community 🤝 venture capital, bootcamp, fellowship, investment, and startup

Type: Incubators & VCs

A global tech investment firm headquartered in Paris with offices in Berlin, Dakar, Dubai, Nairobi, and San Francisco Partech is a global tech investment firm headquartered in Paris, with offices in Berlin, Dakar, Dubai, Nairobi, and San Francisco. We are a team made up of independent thinkers. We are unconstrained by hype, trend or fixed ways of working. We believe in the power of alliance in action, working together and side-by-side with the founders we back, in the shared pursuit of success. We bring together capital, operational experience and strategic support for the entrepreneurs we back from seed through to …

Type: Incubators & VCs

Citeline is a leading global provider of data, analytics, and insights to the life sciences and pharmaceutical industries. With a focus on accelerating drug development and improving clinical outcomes, Citeline empowers organizations to make data-driven decisions at every stage of the drug lifecycle. We offer innovative solutions in clinical trial data, drug development intelligence, regulatory insights, and competitive intelligence. Our services help pharmaceutical companies, contract research organizations (CROs), and biotech firms reduce risks, optimize resources, and increase the success rate of clinical trials. Our unique blend of advanced technology, expert analysis, and industry expertise is what sets us apart. We …

25 similar entities Type: SMB Activities: deeptech healthtech Technologies: Data Analytics

Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI). LimFlow SA, now part of Stryker, is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation. LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations and …

Type: Startup Activities: biotech deeptech healthtech

Programmable Therapeutics for Causal Biology - Science Guides Us. The Genome Powers Us. Patients Ground Us. HAYA Therapeutics is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disease and cancer. The company is using its innovative cell-state modifying platform to gain novel insights into the biology of long non-coding RNAs (lncRNAs), the ‘dark genomes’ information processing features and ‘source code’. HAYA’s lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting Wisper, which is a tissue and cell-specific cardiac lncRNA known to play a role in heart failure. The company is …

6 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Private company data aggregator designed for investment firms in private markets DealPotential is the AI-driven Bloomberg for the private market. The platform aggregates intelligence on 20M+ private companies, 700M+ professionals, and 40K+ deals annually, delivering unmatched visibility across venture capital, private equity, and M&A. With proprietary Due Diligence Intelligence, real-time valuation models, and industry insights, DealPotential helps investors, bankers, and corporates to identify opportunities faster, evaluate risks smarter, and execute deals with confidence. Headquartered in Sweden with a global footprint, DealPotential is trusted by leading investors, corporates, and advisors to simplify complex data and power better decision-making in the opaque …

58 similar entities Type: Startup Activities: fintech Technologies: Data Analytics A.I.

The membership organisation supporting & bringing together UK’s life sciences companies, corporate partners & investors. OBN is a not-for-profit membership network that catalyses growth for the life sciences industry. Whether you’re an emerging entrepreneur, R&D SME, investor, analyst, pharma company, science park, TTO or technology / professional services organisation, we are here to give you opportunities to meet, learn, and grow. OBN organises BioTrinity - OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. Networking Events, Partnering (BioTrinity), Advising: Cluster Analysis and Business Development, Group Purchasing Consortium, Advocacy, Conferences, BioTech, Life Sciences, …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Building Next Generation Companies To Enhance Healthy Lifespan Apollo Health Ventures is a transatlantic early stage Venture Capital firm actively co-founding and investing in transformative healthcare companies targeting age-related diseases and aging itself.

Type: Incubators & VCs

Transactions Made Easy. DealMatrix is a valuation engine that enables startups and investors to quickly and precisely calculate the value of their companies based on various valuation methods, map it against peers, and generate professional reports based on the findings. Investments, Startups, Due Diligence, Business Angels, Venture Capital, Corporate Scouting, Valuation, Investor, Venture Investor, Founder, and Matching

6 similar entities Type: Startup Activities: fintech Technologies: SaaS

Europe's Leading B2B Software Investor Dawn is Europe’s leading specialist B2B software investor, with total commitments of $2bn. Dawn partners with founders building the next generation of global software leaders, supporting them to harness extraordinary teams, exceptional technology and scalable business models to create category-defining global companies. Dawn is an early-stage investor, backing companies from Series A and B, and continuing to fund the top-performing through growth rounds to exit. Its roster of investments includes Mimecast (formerly NASDAQ-listed, taken private by Permira in a $5.8bn transaction), iZettle (sold to PayPal for $2.2bn cash), Tink (purchased by Visa for $2.0bn), LeanIX …

Type: Incubators & VCs

It's Time to Build. Founded in 2009 by Marc Andreessen and Ben Horowitz, Andreessen Horowitz (known as "a16z") is a venture capital firm that backs bold entrepreneurs building the future through technology. We are stage agnostic: We invest in seed to late-stage technology companies, across the consumer, enterprise, bio/healthcare, crypto, fintech and games spaces. a16z is defined by respect for the entrepreneur and the entrepreneurial company building process; we know what it’s like to be in the founder’s shoes. The firm is led by general partners, many of whom are former founders/operators, CEOs, or CTOs of successful technology companies, and …

Type: Incubators & VCs

London Life Sciences Week celebrates life science innovation in London. Hosted by BIA, MedCity and London & Partners. London Life Sciences Week 2025, convened by the BioIndustry Association (BIA), MedCity, and London & Partners, with support from the Mayor of London and the UK Government, will take place from 16-21 November 2025. The week aims to connect biotech leaders, innovators, and global investors throughout a week that celebrates the UK's life sciences sector and its global reach. Centred around the prestigious Jefferies European Healthcare Conference, which draws over 1,300 senior decision-makers and more than 3,300 attendees from international life sciences …

Type: Event

Connecting the best health-tech innovations with leading investors. The future of healthcare happens now! 8-9 May 2024 | Dubai World Trade Centre Alongside Precision Med Exhibition & Summit, Emerge 2050 explores technologies that will transform the future of healthcare with a focus to limit the financial burden. Join the two day conference and networking event and learn about the latest in digital health-tech from innovators, VCs and investors. Healthcare Innovation, Healthcare, Digital Healthcare, and Investment Forum

Type: Event

Truist Securities is the full-service corporate and investment banking arm of Truist Financial Corporation (NYSE: TFC). With a rich history extending back more than 125 years, Truist Securities offers a robust capital markets and investment banking platform that includes a comprehensive array of strategic advisory, mergers and acquisition, and capital markets capabilities for corporate and institutional clients, including sales, trading, and research services in both fixed income and equity. The firm also provides corporate finance, asset finance, risk management, liquidity, and treasury management solutions to meet clients' full spectrum of financial needs. Headquartered in Atlanta, Truist Securities has offices located …

Type: Incubators & VCs

Our Venture Fund invests in early stage startups leveraging machine learning & AI Our Venture Funds invests worldwide in early stage (seed / series A) startups leveraging machine learning / AI across software and health care. We lead, co-lead and participate.

Type: Incubators & VCs

Award-winning communications and marketing for the life sciences. We get you. We get your science. And we bring it to life. First Create The Media is an award-winning communications and marketing agency for the life sciences. We help pioneering biotech innovators get the attention they deserve. Sit down with us and we’ll share your science and your stories with the audiences that matter to you. Why choose First Create The Media? Quality and expertise: Our talented team combines deep and broad scientific and sector knowledge with creative comms skills, so we get it right first time. A great experience: Dedicated …

Type: Media

In February of 2025, Stryker acquired Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases. Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

A European private markets firm Trill Impact is a European private markets firm with EUR 1.4 billion in assets under management, investing in companies that provide solutions for a Sustainable Planet, a Resilient Society and for Healthy People. Trill Impact aims to deliver attractive financial returns to its investors, by exclusively making investments that matter for current and future generations. _______________________________________________________________________________ References to “we”, “us” and “our” in these Terms and Conditions shall, where appropriate, include Trill Impact AB and other members of our group of companies and third parties connected to us. Depending on the context, Trill Impact may …

Type: Incubators & VCs

Trans-Atlantic Biotech Investing Firm SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with who we believe to be top entrepreneurs, scientists and investment partners in an effort to build elite biotechnology companies. SR One’s mission is to translate innovative technologies into potential next-generation medicines that benefit patients with significant unmet medical needs. SR One has offices in San Francisco, CA and London, UK. For more information, please visit www.srone.com.

Type: Incubators & VCs

The Cathay Investments group is a rapidly growing portfolio of businesses spanning multiple sectors in chemicals, logistics, toys and healthcare. We focus predominately on chemicals and logistics and have grown our investments in both sectors substantially with our most recent acquisitions in 2019 enhancing our third party logistics and transport businesses. Further details can be found on our website at www.cathay-investments.com Chemicals Distribution, Third Party Logistics, Freight Forwarding, Toys & Stationery, Educational Medical Models, Optics, Greetings Cards, Transportation, Composites, Fibre & Resins, Mergers & Acquisitions, Logistics, and Warehousing

Type: SMB Activities: transporttech

We strive to be the most trusted, sought-after, driving force behind the leaders shaping the future of healthcare. We know how companies can and should be built. Founded in 2017, Qiming Venture Partners USA is a healthcare venture capital firm and healthcare investor with a combination of deep technical expertise that allows us to identify tomorrow’s innovations early and strong operational experience with a hands-on approach that makes us the investor of choice for early-stage biotech companies. Our partners often are sought-after to be on company boards because of their proven, hands-on approach to supporting CEOs and scaling operations. They …

Type: Incubators & VCs

NEWTIME

Type: Media

Height Capital Markets is a privately-held capital markets firm that provides research, advisory and investment banking services to institutional investors, financial sponsors, and corporations. Our clients rely on Height's investment perspectives in some of the most heavily regulated segments of the economy.

Type: Incubators & VCs

Applied AI in deeptech, healthtech & new economy. Helping great entrepreneurs build 'century-defining' businesses. Deep tech. Health tech. New economy. AI. Helping great entrepreneurs build 'century-defining' technologies & businesses. venture capital, biotech, medtech, healthtech, energy, and AI

Type: Incubators & VCs

Stevenage Bioscience Catalyst (SBC) Stevenage Bioscience Catalyst is a leading location for companies to develop and commercialise cutting edge therapeutics. The Campus is home to major organisations including GSK, the Cell & Gene Therapy Manufacturing Catapult and LifeArc alongside a growing cluster of life sciences start-up companies which together have raised £4b in funding. The facilities have been designed to foster cooperation, scientific and commercial dialogue and interaction between entrepreneurs. Access is offered to business support, equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies.

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech

Join the founders reimagining global habits with new tech infrastructure Join the founders reimagining global habits with new tech infrastructure Startups, Venture Capital, Technology, Infrastructure, AI, Commerce, Mobility, Video, Consumer, Mentorship, Board Member, Machine Learning, Robotics, and Early stage

Type: Incubators & VCs

Nucleome Therapeutics is a biotechnology company using 3D genomics to discover precision medicines for complex diseases Nucleome was founded in 2019. The precision of its 3D genomics technology has the potential to improve drug discovery success rates both by discovering genetically-validated medicines, and by more accurately identifying patients who are likely to benefit from treatments. Nucleome’s platform can be applied to multiple disease indications and cell types, with an initial focus on inflammatory conditions. In addition to building its own pipeline, the company is forging external collaborations in target discovery, target validation, and patient stratification. Nucleome was founded by leading …

Type: Incubators & VCs

Bringing biotech to life. 📺 News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺 Biotech and News

Type: Media

MedNous is a print publication and a website for everyone involved in medical research in Europe. The name is derived from the Greek word for knowledge – nous – and the English word, medical. Both the print and electronic products provide information on the virtual networks of universities, public authorities and bioclusters that have been created in Europe to support life science research. The print publication analyses complex issues that life science professionals need to understand in order to bring their research into commercial development. These issues relate to regulatory affairs, patent law, government research policy and funding. The print …

Type: Media

Aktuelle erhvervsnyheder om virksomheder og personer inden for medicinal, medico, biotek, e-health, rehab mm. MedWatch is a online news site which delivers critical, independent and fair journalism in Danish and English about the pharmaceutical, medtech, rehab and biotech industry. MedWatch is a part of the biggest media group in Denmark, JP/Politikens Hus.

Type: Media

At Anthem Blue Cross and Blue Shield we understand our health connects us to each other. What we all do impacts those around us. So Anthem is dedicated to delivering better care to our members, providing greater value to our customers and helping improve the health of our communities. Independent licensees of the Blue Cross and Blue Shield Association. ANTHEM is a registered trademark of Anthem Insurance Companies, Inc. Products vary by state. Learn more about our plans and legal information at www.anthem.com health insurance, dental insurance, vision insurance, medicare, life insurance, disability insurance, and medicaid

Type: Large company

Production and distribution of radio and television content Born on 4 October 1999: news, programmes, people, languages, sounds and emotions, these are the ingredients of Radio 24. A radio that informs and talks with passion and accompanies the listener throughout the day.

Type: Media

Convening knowledge and creating insights - the journal of the European Healthcare Investor Association Investors in Healthcare is a Google News listed digital business intelligence platform delivering news, data and analytics for private capital across healthcare, life sciences and pharma in Europe. This knowledge creates actionable insights for investors, corporate leaders and advisors. The official journal of the European Healthcare Investor Association, it is the leading independent convener of knowledge for the sector using its MAP framework: - MARKETS (overviews and deep dives including Whitechart PowerPoint slides from leading consulting firms) - ASSETS (company profiles and Curis Intelligence asset portfolio …

Type: Media

European Biotechnology Magazine is the unique information source for the European Life Sciences community. A modern and up-to-date news magazine, the established periodical European Biotechnology Magazine is your source for substantial information on the Biotech, Pharma, Medtech and Chemistry markets of Europe. The goal at european-biotechnology.com is to provide a comprehensive overview over Europe‘s biotech sector! In connection with the print journal European Biotechnology Magazine this is the unique information source for the European Life Sciences-community! biotechnology, lifescience, industry, and europeanbiotechnology

Type: Media

Innovation | Clarity | Execution Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and investment success through turning break-through science into approved medicines or medical products. We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines. As entrepreneurs and experienced, pragmatic investors, we …

Type: Incubators & VCs

International Strategic Healthcare Communications Optimum is an international strategic communications firm specialising in investor relations, corporate and financial communications. Our team of healthcare specialists, based in London and New York, have worked together for many years. Our first-hand experience of analysing, investing and writing about healthcare companies uniquely positions us when advising our clients on building a compelling investment story. Subscribe to our Optimum Perspectives Podcast, where we host industry leaders, and highlight the latest innovation and developments in life sciences. Listen here now: https://www.optimumcomms.com/podcast/ Investor Relations, Financial Communications, Media Relations, Healthcare, Life Sciences, Corporate Communications, and Public Relations

Type: SMB Activities: consulting

We help visionary companies thrive. We support innovative companies fusing digital transformation together with a caring organizational culture.

Type: SMB Activities: healthtech

Committed to creating a new standard of care. Investing in life-changing healthcare technologies.

Type: Incubators & VCs

Multi-stage venture capital firm building and investing in disruptive biotechnology companies.

Type: Incubators & VCs

Investing in the future of medicine Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world’s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We …

Type: Incubators & VCs

Innovation is the Best Medicine RTW is a life sciences investment and innovation firm. Headquartered in New York with offices in London and Shanghai, we invest across the full lifecycle of companies including company creation, early stage venture capital, alternative financing, and public company investments.

Type: Incubators & VCs

Discover. Invest. Cure. The Life Sciences Acceleration Alliance e.V. (LSAA) is a coalition of investors, corporate leaders, and scientific experts dedicated to strengthening Europe’s life sciences ecosystem. We provide a unique and essential voice that bridges venture capital, healthcare, and policy — ensuring that innovation, commercialization, and patient benefit remain at the core of Europe’s competitiveness in a rapidly evolving global landscape. With strong connections across the EU, LSAA advocates for the interests of patients, companies, and investors. We emphasize the critical role of venture capital in turning breakthrough research into life-changing treatments and actively support regulatory reforms that enable …

Type: Incubators & VCs

Pioneering Precision Biocontrols Biotalys is an Agricultural Technology (AgTech) company developing precision biocontrol solutions based on proteins for the protection of crops in both the pre- and post-harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Based on its novel AGROBODYTM technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from …

67 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Converting cancer to a manageable, chronic condition Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need. Inspirna’s lead drug candidate, ompenaclid (RGX-202), is an orally-administered small molecule that targets the CKB/SLC6A8 pathway, which when activated enables the generation of ATP in response to tumor hypoxia. Ompenaclid is currently being tested in multiple mid-stage clinical trials in patients with advanced or metastatic RAS mutant colorectal cancer. Inspirna’s second clinical stage drug candidate, abequolixron (RGX-104), is an oral small molecule activator of LXR/APOE …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Natural Colors Crafted By Fermentation Chromologics is a Danish biotech start-up responding to the strong market pull for novel natural food colorants. We develop fungal fermentation solutions for the production of natural pigments. Our proprietary production process allows not only for a more sustainable production than existing solutions, but is also cost-competitive. Our pigments are produced by a non-GMO fungus, which makes them compliant with the dietary requirements of broad consumer bases such as kosher, halal, and vegan diets. Fermentation, Natural Colorants, University Spin-Out, Downstream Processing, and Color formulation

15 similar entities Type: Startup Activities: agritech biotech deeptech manufacturing Technologies: Bio sourced materials

Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing

75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

London-based venture fund investing in advanced therapies 4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious …

Type: Incubators & VCs

McDermott Will & Emery is now McDermott Will & Schulte. Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better. Attorney Advertising. Prior results do not guarantee a similar outcome.

Type: Large company

Dechert is the law firm that helps business leaders lead. For more than 150 years, we have advised clients on critical issues – from high-stakes litigation to first-in-market transaction structures and complex regulatory matters. Our lawyers in commercial centers worldwide are immersed in the key sectors we serve – financial services, private capital, real estate, life sciences and technology. Dechert delivers unwavering partnership so our clients can achieve unprecedented results. © 2026 Dechert LLP. All rights reserved. This information should not be considered as legal opinions on specific facts or as a substitute for legal counsel. It is provided by …

Type: Large company

The #1 Source for All Things Femtech & Women's Health Innovation The globally leading media platform dedicated to all things femtech and women's health innovation!

Type: Media

Investing in tomorrow's healthcare breakthroughs SV Health Investors is a specialist healthcare fund manager, investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth, healthcare technology. Alongside our core funds, SV manages the Dementia Discovery Fund, focused on discovering and developing novel therapeutics for dementia. Venture Capital, Biotechnology, Medical Devices, Healthcare services, Private Equity, Dementia, Growth Equity, and Healthcare

Type: Incubators & VCs

The Global digital fundraising Summit for PropTech startups Relevation.org is the global digital investment summit in UrbanTech; a 2 days event of match-making between investors (BA, family offices, VC, CVC...) and startups across all the stages of maturity in fund raising process

Type: Event

The need to know ICREA, Catalan Institution for Research and Advanced Studies, is a foundation supported by the Catalan Government and guided by a Board of Trustees. ICREA was created in response to the need to seek new hiring formulas that would make it possible to compete with other research systems on a similar footing by focusing on hiring only the most talented and extraordinary scientists and academics. ICREA is an institution without walls. It works hand in hand with Catalan universities and research centres to integrate ICREA research professors in the Catalan research system. ICREA offers permanent, tenured positions …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

We are Purespring. We are on a mission to radically transform the treatment of kidney diseases. Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases. biotechnology, gene therapy, and kidney diseases

33 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

SCINTIX biology-guided radiotherapy is now FDA cleared. SCINTIX biology-guided radiotherapy now FDA cleared. SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease. cancer care, radiation therapy, life sciences, medical devices, biotechnology, oncology, manufacturing, PET scanner, electrical engineering, product engineering, algorithms engineer, new product development, and software engineering

Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. Together with our research collaborations with premiere institutions …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We champion the benefits of engineered cell therapies & genetic medicines for patients, healthcare systems & society. The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems, and society. As a community, ARM builds the future of medicine by convening the sector, facilitating influential exchanges on policies and practices, and advancing the narrative with data and analysis. We actively engage key stakeholders to enable the development of advanced therapies and modernize healthcare systems so that patients benefit from durable, potentially curative treatments. As the …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech deeptech biotech

Networking Biotechnology - Creating Sustainability CLIB (Cluster Industrial Biotechnology) is an international open innovation cluster of large companies, SMEs, academic institutes and universities, as well as other stakeholders active in biotechnology and bioeconomy as a whole. The cluster comprises over 100 members with a share of about 25 % international members. The overall goal of CLIB is to network stakeholders along and across value chains and to identify new opportunities for innovation, projects, and business. Through this, the cluster develops cross-sectoral biotechnological solutions for sustainable processes and products. Pertinent project areas are identified by the CLIB team in conjunction with …

Type: NGO, Think-tanks, Ed, & Culture Activities: it services greentech

NF2 BioSolutions UK & Europe is a UK registered charity and an arm of the global NF2 BioSolutions organisation. NF2 BioSolutions UK & Europe is a UK charity (Registered in England and Wales charity no. 1189618) Accelerating research into gene therapy, bacteriotherapy, immunotherapy, antibodies, inflammation & T-cells for a treatment or CURE to NF2. Our vision is a world where those living with NF2 will have access to cutting-edge solutions to live full and productive lives, free from daily physical and emotional pain or suffering. NF2 is a rare genetic disorder that affects approximately 1/35,000 individuals globally which results in …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech healthtech

A Contract Research Organisation which has an integrated drug discovery platform in Ahmedabad, India and Cambridge, UK. Founded in 2005, o2h discovery is a Contract Research Organisation which has an integrated drug discovery platform operating from our state-of-the-art research centre in India and The Mill SciTech Park, Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development. o2h discovery has developed and launched its proprietary application Chemistry in the CloudTM (CITC), the world’s …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech Technologies: Synthetic Biology

Our mission: bacteria for therapy Our mission is to use probiotic bacteria to improve health and wellbeing. For this purpose we explore the human microbiome: We are developing microbiological therapies for intestinal and respiratory health, as well as to improve immune function. Pioneering the understanding of the human microbiome as a basis we are a global leader in microbiome research and evidence based probiotics – since 1954. State of the art technologies in our biotech-laboratory and close interaction with in-house physicians and medical scientists enable us to create first in kind innovative products, such as Symbioflor® 1 – one of …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech biotech

Sector-focused Investment Banking, Equity Research, Sales & Trading, Strategic Advisory & Corporate Access Services. Founded in 1868, H.C. Wainwright & Co. is a New York–based full-service investment bank providing Equity Research, Sales & Trading, Corporate Access, and Strategic Advisory services to emerging growth companies and institutional investors worldwide. With one of the largest equity research teams focused on small- to mid-cap companies, we specialize in sectors like biotechnology, healthcare, life sciences, energy, and cryptocurrency helping clients navigate complex markets and uncover opportunities. Ranked the #1 Placement Agent by Informa since 1998, we are also the most active placement agent for …

Type: NGO, Think-tanks, Ed, & Culture Activities: fintech

AFCC member companies are industrial biotechnology companies directly engaged in all things related to biobased economy. The Alternative Fuels & Chemicals Coalition (AFCC) is a collaborative effort that is guided by the shared objectives of its industry participants. AFCC builds on the government affairs expertise that already is in place to support federal agency programs important to the alternative fuels, renewable chemicals, biobased products, and sustainable aviation fuels (SAF) industries and monitor and speak out on pending legislation in the U.S. Congress. The purpose of the coalition is to ensure issues important to the coalition are not overlooked and get …

Type: NGO, Think-tanks, Ed, & Culture Activities: cleantech greentech

Downstream infrastructure for tomorrow's energy economy Triten Energy Partners invests in downstream infrastructure through opportunistic asset acquisitions and development projects that produce valuable end-products for the global refined products, renewable fuels and petrochemical industries.

Type: SMB Activities: cleantech greentech energytech Technologies: Decarbonization

A global business facilitator since 1979, Dubai World Trade Centre (DWTC) is home to the region’s leading purpose-built convention and exhibition centre. DWTC provides a platform for connecting people, products, innovation and ideas from around the world through a dynamic calendar of international trade exhibitions and its own roster of sector leading mega events. As a designated free zone, complemented by award-winning commercial real estate, DWTC plays an integral role in Dubai and the region’s growth story with an estimated total economic output of AED 200 Billion, attracting over 30 Million business visitors to Dubai over the past four decades. …

Type: Public

Innovation in Dermatology PinCell is a biotechnology company targeting a novel pathway for the treatment of rare, severe dermatological diseases with high unmet medical need, through the development of a first-in-class, anti-apoptotic human anti-FasL mAb. Based in Milan, Italy, PinCell was founded in October 2008 as an academic spin-off of the University of Modena and Reggio Emilia by world-class dermatology experts, is supported by an international Scientific Advisory Board and is led by a team of seasoned industry professionals and scientific researchers. PinCell’s lead program targets a rare autoimmune bullous disease called Pemphigus, which is characterized by blistering and erosions …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech Technologies: Synthetic Biology

Type:

EQT is a global investment organisation focused on active ownership strategies. We are a purpose-driven global investment organisation with more than three decades of consistent investment performance across multiple geographies, sectors, and strategies

Type: Incubators & VCs

Revolutionizing the Future of Bio-ingredients BIOWEG, founded in 2019 in Germany, is a purpose-driven organization powered by conscious ChemDesign. We match Bio-innovation to business problems. We explore and combine biotechnology, material science, and molecular simulation learning to create advanced sustainable bio-based high-performance ingredients. Our ingredients are 100% animal free, globally scalable, and sustainably produced without harsh chemicals. We work with results-oriented, forward-thinking companies, and consumer brands with global scale in the cosmetics, personal care, nutraceuticals, agricultural coatings, and food/beverage sectors who desire highly differentiated and sustainable science-based ingredient technologies. Material Science, Fermentation , Green Chemistry, Alternative Ingredients, Biobased Materials, Biodegradabe, …

94 similar entities Type: Startup Activities: cleantech deeptech greentech Technologies: Bio sourced materials New Materials

Global, independent, strategic management consultancy - Food, feed, fuel & fibre Prassack Advisors provides strategic advice and ongoing intelligence for clients in the global agriculture, food, water and energy sectors. By helping established and emerging innovators we deliver solutions that matter for farmers, agribusiness and food producers. Our experienced team employs a unique research approach which combines a focus on primary research and our extensive “ground truthing” network to deliver actionable insights, connections and competitive advantage to our clients. For more information, please visit our website at www.prassackadvisors.com. Or reach out directly via email to info@prassackadvisors.com or call 1-720-675-9456. Innovation …

61 similar entities Type: Startup Activities: agritech cleantech greentech smart city Technologies: IoT

We read all of the business news so you don’t have to. Subscribe today. Executive briefings of the news you need. Join the waitlist for product launch mid-2024: https://docs.google.com/forms/d/e/1FAIpQLSeF3zupwgUiJ90O2dy5IXdCb6ZaYT28w7JCgpcUMi5z912tvA/viewform Founder: Jason Calacanis Jason Calacanis co-founded and was the CEO of Weblogs, Inc., a network of popular weblogs that was sold to AOL in November 2005. Upon joining AOL, he was appointed senior vice president. In addition, he was named general manager of AOL’s Netscape and was responsible for the July 2006 relaunch of the iconic browser as a social bookmarking news site. Investors include: Sequoia Capital, CBS, Elon Musk, Matt …

Type: Startup Activities: it services Technologies: A.I.

We help founders win, bigger Headline is a venture capital firm with teams on the ground in 8 cities around the world. We invest across geographies, stages, and sectors, from consumer and fintech to infrastructure and software. Once we commit to a team, we go to the ends of the earth to make their success global. Our Early Stage Funds, based in the US, Europe, Asia, and Latin America, back Early Stage companies locally, while our Venture Growth Fund invests globally from Series B and beyond. This allows us to see local trends up close, partner with winning founders, and …

Type: Incubators & VCs

Corteva Agriscience combines industry-leading innovations, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, biologicals, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those …

Type: Large company

Daily news and insights for private equity and venture capital. Free newsletter here! https://www.altassets.net/register AltAssets connects LPs and GPs worldwide. We have been serving the global private equity industry for over a decade and have become established as a trusted source of independent news and views on the industry by thousands of professionals worldwide. Our online news service is the world's most widely used source of information with 450,000 individuals accessing the site to gain insights on investments in private equity, venture capital, real estate and infrastructure funds. We also host invitation-only LP-GP Forums to connect active LPs with the …

Type: Media

Exceptional Ventures is an early-stage VC firm investing in entrepreneurs and companies that are improving lives. At Exceptional Ventures, our motto is Believing in Believers. We believe that innovative businesses can make the world a better place, and we believe in entrepreneurs that feel the same. It is our mission to support them with our expertise and capital, and to help them build a better future. We focus on businesses that are helping people live healthier, happier, longer lives. Our portfolio ranges from sustainable consumer products to applications focused on mental and physical health, and on the future of foods. …

Type: Incubators & VCs

Specialized in the future since 1737 Everything to preserve and build your assets Your wishes and goals are central to us and you will receive expert, tailor-made advice. Our private bankers pay attention to your personal situation. This way you benefit from all our knowledge and expertise, so that you can make further progress with your assets. ✔ Expert: benefit from our centuries of knowledge and expertise ✔ Personal: your own private banker who knows and understands your personal situation ✔ Result-oriented: we help you realize as many financial dreams and goals as possible Private Banking, Business Banking, and Sector …

Type: Large company Activities: fintech

Investing at inception in scientists developing breakthroughs that will shape our future. Pillar VC is with you from the beginning. We invest in scientists developing the breakthroughs that will define our future. Our thesis is simple: scientific progress has never been more crucial or more accelerated. Our team partners with technically brilliant dreamers who see past impossible to inevitable. venture capital, investing, and startups

Type: Incubators & VCs Activities: fintech deeptech

Sustainability in Asset Management. Click below to visit our website ⬇️ and Follow #investing4tomorrow Candriam is a global multi-specialist asset manager with offices across Europe. As pioneer in sustainable investing, we’ve delivered innovative, diversified solutions across asset classes for over 25 years. No wonder we chose a name that stands for Conviction AND Responsibility In Asset Management—values that have guided us since 1998. We invest with purpose, driven by strong beliefs and a responsible approach. At Candriam, we value autonomy, inclusion, and personal development. Ready to shape tomorrow with us? 💼 Discover our current vacancies: https://www.candriam.com/en/professional/career/ 🌐 Learn about our …

Type: Incubators & VCs Activities: fintech greentech Technologies: Decarbonization

The best of economic-financial information, at your disposal, always. MF-Milano Finanza is the national financial and economic newspaper, with the primacy of information on the stock market, economy, investments and markets. A direct line to Piazza Affari and the main world stock exchanges. With dedicated sections: Online Trading, Technical Analysis, ETF, Covered Warrants, Private Equity, Shipping & Logistics and on Saturdays with Milano Finanza important insights into the world of managed savings, securities and real estate investment. The correctness, truthfulness and authoritativeness of the newspaper are recognized by the target and by professionals both at a national level (partnership with …

Type: Media

Global investors developing themes and offering solutions to companies across all stages of growth Sixth Street is a global investment firm with over $130 billion in assets under management and committed capital.* The firm uses its long-term flexible capital, data-enabled capabilities and One Team culture to develop themes and offer solutions to companies across all stages of growth. Founded in 2009, Sixth Street has more than 700 team members including over 300 investment professionals operating globally. *For more information, visit www.sixthstreet.com. Disclaimer information: https://sixthstreet.com/terms-of-use/

Type: Incubators & VCs

The first publisher specializing in news and services on private investments in venture and debt capital EdiBeez is the publisher of BeBeez.it and CrowdfundingBuzz.it BeBeez is an online newspaper registered with the Court of Milan (Authorization no. 102 of 3 April 2013), born in the spring of 2013 from an idea by Stefania Peveraro (service manager of MF Milano Finanza) and Anna Gervasoni (general director of the Italian Association of Private Equity and Venture Capital, AIFI). Crowdfunding Buzz is a magazine dedicated to collecting news and information relating to all forms of crowdfunding. Born in December 2014 on the initiative …

Tags: H2020 Type: Media

Investing at the Frontier. Backing breakout researchers and entrepreneurs solving the toughest problems. OUP (Osage University Partners) is a venture capital firm that invests in breakthrough start-ups emerging from the world’s leading research labs and innovation ecosystems. We leverage our global network of 150+ university partners as well as deep relationships with founders, entrepreneurs, and industry to source and support the translation of cutting-edge research into transformative companies with impact. Founded in 2009 and headquartered in Philadelphia, OUP manages over $800 million and has invested in more than 150 life science and technology start-ups. For more information, visit oup.vc. Physical …

Type: Incubators & VCs

Your business partner LCA is an independent, full-service law firm, specialised in providing legal assistance to companies worldwide. Our offices are in Italy (Milan, Rome, Genoa, Treviso), Belgium (Brussels), and the United Arab Emirates (Dubai), where we operate in an International Partnership with IAA Middle East Legal Consultants LLP. LCA has over 280 professionals active in all major areas of commercial, corporate, banking, financial, insolvency, administrative, tax, criminal, competition, real estate, labor, intellectual property, and family wealth protection law. The firm also operates in specialist areas such as sports law, technology, transport, insurance, energy, food law, and art law, among …

30 similar entities Type: SMB Activities: fintech legaltech

Building Canada's life sciences industry from sea to sea With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, we use our scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent — and re-invest our returns back into the Canadian industry to ensure its long-term sustainability. www.admarebio.com Avec des bureaux situés à Montréal, Vancouver …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech biotech

Jefferies, the global investment banking firm serving clients for more than 60 years. Jefferies is a leading global, full-service investment banking and capital markets firm that provides advisory, sales and trading, research and wealth and asset management services. With more than 40 offices around the world, we offer insights and expertise to investors, companies and governments. More about our company can be found at www.jefferies.com. Investment Banking, Fixed Income, Equities, Research & Strategy, Wealth Management, and Financial Services

Type: Incubators & VCs

The award-winning trade association for the innovative life sciences and biotech companies in the UK The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation. BIA is a trade association with 600+ member companies including: - Start-ups, biotechnology and innovative life science companies - Pharmaceutical and technological companies - Universities, research centres, tech transfer offices, incubators and accelerators - A wide range of life science service providers: investors, lawyers, IP consultants, IR agencies BIA is the key thought leader …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

ASGCT is the primary membership organization for professionals working in gene and cell therapy. The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies. The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech

The Oxford Science Park is one of the most influential science, technology and business environments in the UK for more than 2,500 people in over 70 companies, ranging from start-ups to SMEs and multi-national organisations. It was created in 1991 and is owned and managed by Magdalen College Oxford, one of Oxford’s oldest and most famous colleges with a tradition of academic excellence and entrepreneurship. The Park continues to uphold the College’s heritage. People who work here enjoy 75 acres of beautifully landscaped grounds and an atmosphere of discovery, innovation and entrepreneurship. Offices, Laboratories, and Conference and Meeting rooms for …

Type: Incubators & VCs Activities: deeptech edtech

Voima Ventures helps founders accelerate the growth of deep technology ventures to global markets. Voima Ventures helps founders accelerate the growth of deep technology ventures to global markets. We shed light on the ideas and technology that require time and courage to build. The way we work is simple: we combine science-driven innovation together with the Nordic serial entrepreneurial experience and a global mindset.

Type: Incubators & VCs

For the people and ideas that will change the world. Octopus Ventures, part of Octopus Group, is one of the largest and most active venture capital investors in the UK and Europe. We’re on a mission to invest in the people, ideas and industries that will change the world. We back entrepreneurs ─ from the first cheque their business receives, right through to IPO. We manage £1.8bn and are investing in more than 200 businesses, focusing on the companies solving three of the world’s biggest problems: those building a sustainable planet, empowering people, and revitalising healthcare. We know what it …

Type: Incubators & VCs

The major trends of the 21st century, notably globalisation, digitisation, demographic change, recent developments within the EU, and climate change all represent major challenges for German business to tackle. If we are to successfully address these issues, we need to develop our social market economy into a social-ecological market economy. This is the over-arching task for the Federal Ministry for Economic Affairs and Climate Action. Wirtschaft, Digitalisierung, Handelspolitik, Mittelstandspolitik, Energiewende, Europa, Wirtschaftliche Entwicklung, Industriepolitik, Luft- und Raumfahrt, Erneuerbare Energien, Außenwirtschaftsförderung, Existenzgründung, Tourismuspolitik, Energieeffizienz, Maritime Wirtschaft, Netzausbau, and Industrie 4.0

Type: Public Activities: cleantech greentech

Advancing crystallography and structural science through primary research publication and extensive outreach activities The IUCr is an International Scientific Union. Its objectives are to promote international cooperation in crystallography and to contribute to all aspects of crystallography, to promote international publication of crystallographic research, to facilitate standardization of methods, units, nomenclatures and symbols, and to form a focus for the relations of crystallography to other sciences. Publishing, Crystallography, Open Access, Science, journals, online communities, and databases

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Investors in companies that make the difference, partner of entrepreneurial visionaries We are investors in companies that make the difference. We trust in great entrepreneurs, we partner with hard-working visionaries. Innogest is a Venture Capital firm focused on seed and early stage ventures, with more than € 200 milion of capital under management. We have over 100 years of cumulative professional experience in the digital and the healthcare fields. Innogest invests in high potential companies through a direct share in their equity and pays special attention to market potential and size. Innogest leverages its extensive network of contacts, working alongside …

Tags: H2020 Type: Incubators & VCs

Inovia is a VC firm that partners with founders to build impactful and enduring global companies #CompanyBuilders ​Inovia Capital partners with founders to build impactful and enduring global companies. With an operator-led mindset, we provide multi-stage support, mentorship, and access to a worldwide network. Inovia manages over US$2.5B in assets with operations in Montreal, Toronto, Calgary, the Bay Area, London, and Abu Dhabi. For more information, visit inovia.vc. Entrepreneurial Capital, Seed and Early Stage Venture Capital, and Growth Capital

Type: Incubators & VCs

We build breakthrough biotech companies with remarkable life science entrepreneurs. Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by doing good, we have been building breakthrough biotech startups since 1993. We work side by side with exceptional scientists and entrepreneurs to translate high impact science into medicines for patients. Our seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value. Biotech and Venture Capital

Type: Incubators & VCs

Wellington Partners is one of the most successful pan-European venture capital firms. With funds totalling over € 800 million, we have invested throughout Europe in companies that have the potential to become real market leaders for more than 15 years. We are committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically lead financing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, our own commitment can go as high as € 15 million. Providing funding is only one part of our business. After funding, the entrepreneurs …

Type: Incubators & VCs